Provided by Tiger Fintech (Singapore) Pte. Ltd.

GT Biopharma Inc.

2.28
-0.0019-0.08%
Post-market: 2.350.0700+3.07%16:00 EDT
Volume:10.90K
Turnover:25.09K
Market Cap:5.78M
PE:-0.33
High:2.32
Open:2.30
Low:2.28
Close:2.28
Loading ...

GT Biopharma files to sell 625,283 shares of common stock for holders

TIPRANKS
·
07 Mar

GT Biopharma to Participate in the 10th Anniversary of the Innate Killer Summit

GlobeNewswire
·
04 Mar

GT Biopharma Announces Exercise of Warrants

GlobeNewswire
·
26 Feb

GT Biopharma could report Phase 1 trial data later this year, says Roth MKM

TIPRANKS
·
26 Feb

GT Biopharma Announces Request for Withdrawal of Form S-1 Registration Statement

THOMSON REUTERS
·
25 Feb

GT Biopharma Announces Request for Withdrawal of Form S-1 Registration Statement

GlobeNewswire
·
25 Feb

GT Biopharma Inc - Initial Data From Phase 1 Trial Expected in 2025

THOMSON REUTERS
·
27 Jan

GT Biopharma Announces First Patient Dosed in Phase 1 Trial of Gtb-3650, Second-Generation Trike for the Treatment of Hematologic Malignancies

THOMSON REUTERS
·
27 Jan

GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-3650, Second-Generation TriKE for the Treatment of Hematologic Malignancies

GlobeNewswire
·
27 Jan

GT Biopharma Slightly Lower Pre-Bell After Filing of Public Offering Registration

MT Newswires Live
·
24 Dec 2024

GT Biopharma files automatic mixed securities shelf

TIPRANKS
·
24 Dec 2024

BRIEF-Gt Biopharma Receives Nasdaq Delisting Notice For Falling Below $2.5 Million Equity Minimum

Reuters
·
28 Nov 2024

GT Biopharma Inc - Receives Nasdaq Delisting Notice for Falling Below $2.5 Mln Equity Minimum

THOMSON REUTERS
·
28 Nov 2024

BRIEF-Gt Biopharma Says Entered Into Investigator Initiated Clinical Trial Agreement With Regents Of University Of Minnesota

Reuters
·
21 Nov 2024

GT Biopharma Inc - the University Shall Sponsor an Investigational New Drug Application for Ind 165546 Gtb-3650

THOMSON REUTERS
·
21 Nov 2024

GT Biopharma Inc - Entered Into Investigator Initiated Clinical Trial Agreement With Regents of University of Minnesota

THOMSON REUTERS
·
21 Nov 2024

North American Morning Briefing: Russia's Nuclear Doctrine News Triggers Risk-Aversion

Dow Jones
·
19 Nov 2024

GT Biopharma Q3 EPS $(1.53) Up From $(1.77) YoY

Benzinga
·
15 Nov 2024

GT Biopharma Reports Third Quarter 2024 Financial Results

THOMSON REUTERS
·
15 Nov 2024

GT Biopharma Reports Third Quarter 2024 Financial Results

GlobeNewswire
·
15 Nov 2024